8096739

Source:http://linkedlifedata.com/resource/pubmed/id/8096739

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0008838, umls-concept:C0015385, umls-concept:C0015967, umls-concept:C0025202, umls-concept:C0031327, umls-concept:C0178602, umls-concept:C0204727, umls-concept:C0205409, umls-concept:C0396670, umls-concept:C0600688, umls-concept:C1173600, umls-concept:C1261473, umls-concept:C1273870, umls-concept:C1514811, umls-concept:C1561577, umls-concept:C1706462
pubmed:dateCreated	1993-5-12
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8008541
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Dactinomycin, http://linkedlifedata.com/resource/pubmed/chemical/Melphalan
pubmed:status	MEDLINE
pubmed:issn	0927-3042
pubmed:author	pubmed-author:BoyMM, pubmed-author:BrownDD, pubmed-author:FletcherW SWS, pubmed-author:LebredoLL, pubmed-author:MoseleyH SHS, pubmed-author:SolkyH JHJ, pubmed-author:WolteringE AEA
pubmed:issnType	Print
pubmed:volume	62
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	241-4
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:8096739-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:8096739-Bone Neoplasms, pubmed-meshheading:8096739-Chemotherapy, Adjuvant, pubmed-meshheading:8096739-Chemotherapy, Cancer, Regional Perfusion, pubmed-meshheading:8096739-Cisplatin, pubmed-meshheading:8096739-Combined Modality Therapy, pubmed-meshheading:8096739-Dacarbazine, pubmed-meshheading:8096739-Dactinomycin, pubmed-meshheading:8096739-Evaluation Studies as Topic, pubmed-meshheading:8096739-Extremities, pubmed-meshheading:8096739-Humans, pubmed-meshheading:8096739-Hyperthermia, Induced, pubmed-meshheading:8096739-Incidence, pubmed-meshheading:8096739-Melanoma, pubmed-meshheading:8096739-Melphalan, pubmed-meshheading:8096739-Neoplasm Metastasis, pubmed-meshheading:8096739-Osteosarcoma, pubmed-meshheading:8096739-Rhabdomyolysis, pubmed-meshheading:8096739-Skin Neoplasms, pubmed-meshheading:8096739-Treatment Outcome
pubmed:year	1993
pubmed:articleTitle	Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
pubmed:publicationType	Journal Article